Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Breadcrumb

  1. Emmes Group

Responsiveness of the National Eye Institute - Refractive Error Quality of Life (NEI-RQL) instrument to surgical correction of refractive error

Go back to Resources

Responsiveness of the National Eye Institute - Refractive Error Quality of Life (NEI-RQL) instrument to surgical correction of refractive error

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Recombinant human growth hormone post-renal transplantation in children: a randomized controlled study of the NAPRTCS

Go back to Resources

Recombinant human growth hormone post-renal transplantation in children: a randomized controlled study of the NAPRTCS

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years

Go back to Resources

Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Quality control issues in a genetic repository-the Age-Related Eye Disease Study experience

Go back to Resources

Quality control issues in a genetic repository-the Age-Related Eye Disease Study experience

Authors:

Location:

Go back to Resources

Psychometric properties of the National Eye Institute - Refractive Error Quality of Life (NEI-RQL) instrument

Go back to Resources

Psychometric properties of the National Eye Institute - Refractive Error Quality of Life (NEI-RQL) instrument

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Potential public health impact of Age-Related Eye Disease Study results. AREDS Report No.11

Go back to Resources

Potential public health impact of Age-Related Eye Disease Study results. AREDS Report No.11

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Patterns of RSV Disease Prophylaxis in Infants with Congenital Heart Disease (CHD): Preliminary Results From the 2002-2003 Palivizumab Outcomes Registry

Go back to Resources

Patterns of RSV Disease Prophylaxis in Infants with Congenital Heart Disease (CHD): Preliminary Results From the 2002-2003 Palivizumab Outcomes Registry

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Long-term survival following simultaneous kidney-pancreas transplantation versus kidney transplantation alone in patients with type 1 diabetes mellitus and renal failure

Go back to Resources

Long-term survival following simultaneous kidney-pancreas transplantation versus kidney transplantation alone in patients with type 1 diabetes mellitus and renal failure

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Group patterns of RSV disease prophylaxis in infants with congenital heart disease (CHD): preliminary results from the 2002-2003 Palivizumab Outcomes Registry

Go back to Resources

Group patterns of RSV disease prophylaxis in infants with congenital heart disease (CHD): preliminary results from the 2002-2003 Palivizumab Outcomes Registry

Authors:

Location:

Go back to Resources

For the Prograf Study Group. Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months

Go back to Resources

For the Prograf Study Group. Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 134
  • Page 135
  • Page 136
  • Page 137
  • Current page 138
  • Page 139
  • Page 140
  • Page 141
  • Page 142
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions